Clinical Practice

Use the tool below to view all available Global Oncology Academy Series

Androgen Receptor Emerges as a Marker of Differentiation in Endometrial Cancer
Androgen Receptor Emerges as a Marker of Differentiation in Endometrial Cancer
Project Oncology®
Androgen Receptor Emerges as a Marker of Differentiation in Endometrial Cancer
Early-Onset Endometrial Cancer: Bridging the Gap Between Age and Outcome
Early-Onset Endometrial Cancer: Bridging the Gap Between Age and Outcome
Project Oncology®
Early-Onset Endometrial Cancer: Bridging the Gap Between Age and Outcome
Investigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study
Investigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study
Project Oncology®
Investigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study
- Jorge Nivea, MD
Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
Project Oncology®
Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
- Vanessa Helou, MD
Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
Project Oncology®
Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
- George Laliotis, MD, MPH, MHA
TIL^plus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
TIL^plus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Project Oncology®
TIL^plus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
Project Oncology®
Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Project Oncology®
Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Poster Pearl: Axatilimab’s Impact on Fibrosis-Dominant Organs in cGVHD
Poster Pearl: Axatilimab’s Impact on Fibrosis-Dominant Organs in cGVHD
Project Oncology®
Poster Pearl: Axatilimab’s Impact on Fibrosis-Dominant Organs in cGVHD
- Charles Turck, PharmD, BCPS, BCCCP
- Daniel Wolff, MD
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
Global Oncology Academy
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
- Daniel J. George, MD
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Project Oncology®
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
Global Oncology Academy
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
- Megan Kruse, MD
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Clinician's Roundtable
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
- Ihtisham Ahmad
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Clinician's Roundtable
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Strategic Sequencing in Steroid-Refractory Chronic GVHD: Adapting to a New Landscape
Strategic Sequencing in Steroid-Refractory Chronic GVHD: Adapting to a New Landscape
Project Oncology®
Strategic Sequencing in Steroid-Refractory Chronic GVHD: Adapting to a New Landscape
- Jennifer Caudle, DO
- Doris M. Ponce, MD, MS
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
Clinician's Roundtable
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
- Peter Buch, MD, FACG, AGAF, FACP
- A. Mark Fendrick, MD

Clinical Practice

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

Clinical Practice

Popular

Title

Share on ReachMD

Welcome to the newGlobal Oncology Academy website.

Welcome to the new
Global Oncology Academy website.